Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is percutaneous liver biopsy safe in patients with hepatitis C and end-stage renal disease?

Nature Clinical Practice Gastroenterology & Hepatology volume 5, pages 420–421 (2008)Cite this article

Pawa S et al. (2007) Percutaneous liver biopsy is safe in chronic hepatitis C patients with end-stage renal disease. Clin Gastroenterol Hepatol 11: 1316–1320

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Firpi RJ et al. (2005) Short recovery time after percutaneous liver biopsy: should we change our current practices? Clin Gastroenterol Hepatol 3: 926–929

    Article  Google Scholar 

  2. Sohal AS et al. (2006) Uremic bleeding: pathophysiology and clinical risk factors. Thromb Res 118: 417–427

    Article  CAS  Google Scholar 

  3. Sterling RK et al. (1999) Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 94: 3576–3582

    Article  CAS  Google Scholar 

  4. Cotler SJ et al. (2002) Characteristics of hepatitis C in renal transplant candidates. J Clin Gastroenterol 35: 191–195

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Lisa Richards, Editorial Assistant, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. ER Kallwitz is a Hepatology Fellow, and SJ Cotler is an Associate Professor of Medicine and Chief of the Section of Hepatology, at the University of Illinois, Chicago, IL, USA.,

    Eric R Kallwitz & Scott J Cotler

Authors
  1. Eric R Kallwitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scott J Cotler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eric R Kallwitz.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kallwitz, E., Cotler, S. Is percutaneous liver biopsy safe in patients with hepatitis C and end-stage renal disease?. Nat Rev Gastroenterol Hepatol 5, 420–421 (2008). https://doi.org/10.1038/ncpgasthep1183

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep1183

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing